NOVO.B.DK

306.45

-4.52%↓

GMAB.DK

1,956.5

-1.78%↓

HLUNB.DK

43.72

-1.35%↓

ZEAL.DK

530.8

-0.86%↓

NOVO.B.DK

306.45

-4.52%↓

GMAB.DK

1,956.5

-1.78%↓

HLUNB.DK

43.72

-1.35%↓

ZEAL.DK

530.8

-0.86%↓

NOVO.B.DK

306.45

-4.52%↓

GMAB.DK

1,956.5

-1.78%↓

HLUNB.DK

43.72

-1.35%↓

ZEAL.DK

530.8

-0.86%↓

NOVO.B.DK

306.45

-4.52%↓

GMAB.DK

1,956.5

-1.78%↓

HLUNB.DK

43.72

-1.35%↓

ZEAL.DK

530.8

-0.86%↓

NOVO.B.DK

306.45

-4.52%↓

GMAB.DK

1,956.5

-1.78%↓

HLUNB.DK

43.72

-1.35%↓

ZEAL.DK

530.8

-0.86%↓

Search

Coloplast A-S (Class B)

Închisă

578.2 1.01

Rezumat

Modificarea prețului

24h

Curent

Minim

569.8

Maxim

582.4

Indicatori cheie

By Trading Economics

Venit

-107M

805M

Vânzări

28M

7B

P/E

Medie Sector

35.437

106.172

EPS

3.88

Randament dividend

4.01

Marjă de profit

11.569

Angajați

16,744

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.01%

2.31%

Statistici piață

By TradingEconomics

Capitalizare de piață

-8B

129B

Deschiderea anterioară

577.19

Închiderea anterioară

578.2

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 nov. 2025, 23:07 UTC

Market Talk

Evidence Of Broad Australian Economic Upswing Mounts -- Market Talk

20 nov. 2025, 22:22 UTC

Market Talk

Auckland Airport Has Edge Over Transurban In Infrastructure Stocks -- Market Talk

20 nov. 2025, 22:08 UTC

Market Talk

Revenues of Texas Battery Projects Drop Sharply -- Market Talk

20 nov. 2025, 21:57 UTC

Câștiguri

Walmart Reports Strong Sales Growth, Raises Outlook -- 5th Update

20 nov. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Health Care Roundup: Market Talk

20 nov. 2025, 21:50 UTC

Market Talk
Câștiguri

Financial Services Roundup: Market Talk

20 nov. 2025, 21:31 UTC

Câștiguri

Nvidia's Strong Results Show AI Fears Are Premature -- Update

20 nov. 2025, 21:23 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov. 2025, 21:07 UTC

Câștiguri

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:06 UTC

Câștiguri

Webull 3Q Rev $156.9M >BULL

20 nov. 2025, 21:06 UTC

Câștiguri

Webull 3Q EPS 7c >BULL

20 nov. 2025, 21:05 UTC

Câștiguri

Intuit 1Q Sales Jump, CFO Cites AI Demand From Mid-Sized Businesses -- Interview

20 nov. 2025, 21:04 UTC

Câștiguri

Mid-Sized Businesses Want to Automate Tasks With AI, Intuit CFO Says >INTU

20 nov. 2025, 21:04 UTC

Câștiguri

Intuit's AI Offerings Attracted More Mid-Sized Businesses in 1Q, CFO Says >INTU

20 nov. 2025, 21:04 UTC

Câștiguri

Intuit Earnings Beat Estimates as Company Leans Into AI Strategy -- Barrons.com

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q Rev $4.52B-$4.55B >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees FY26 GAAP Operating Income $5.78B to $5.86B

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q Adj EPS $3.63-Adj EPS $3.68 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Global Business Solutions Rev Growth of 15.5% to 16.5%, Excluding Mailchimp

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Consumer Rev Growth of 8% to 9%

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Expects FY26 Global Business Solutions Rev Growth of 14% to 15%

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Rev $21B-$21.19B >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Adj EPS $22.98-Adj EPS $23.18 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit 1Q Consumer Rev $894M

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Sees 2Q EPS $1.76-EPS $1.81 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 Guidance

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit Backs FY26 EPS $15.49-EPS $15.69 >INTU

20 nov. 2025, 21:00 UTC

Câștiguri

Intuit 1Q Global Business Solutions Rev $3B

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat